Skip to content

Acupuncture for Infectious Mononucleosis Trial

Acupuncture for Infectious Mononucleosis Trial

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00598988
Acronym
AIM
Enrollment
3
Registered
2008-01-23
Start date
2008-01-31
Completion date
2008-12-31
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Mononucleosis

Keywords

infectious mononucleosis, mono, acupuncture

Brief summary

The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Detailed description

This study examines the feasibility of treating adolescents and young adults diagnosed with infectious mononucleosis with acupuncture. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Interventions

10 treatments over 6 weeks

OTHERstandard medical care

standard care as provided by primary physician

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* mono diagnosis confirmed by lab test * 21 days or less between start of symptoms and diagnostic test * presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire) * no other illnesses present * meets residency requirement

Exclusion criteria

* insufficient communication in English * unable to begin acupuncture within 21 days of diagnostic test * acupuncture use currently or in the preceding 3 months * currently under the care of a TCM practitioner * unwilling to be randomized

Design outcomes

Primary

MeasureTime frame
Chalder Fatigue Questionnaire12 weeks

Secondary

MeasureTime frame
MOS SF-3612 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026